Pharma BD Deal Intelligence

Novartis AG / MorphoSys AG

2024 · Acquisition/Merger · $2.9B · Complete

Announcement Sentiment

38

Skeptical

Outcome Score

36

Underwhelmed — fell short of the thesis.

Novartis acquired MorphoSys for ~$2.9B for oncology and immunology antibodies.

Key facts

Announced Feb 05, 2024
Closed May 30, 2024
Deal value $2.9B
Deal type Acquisition/Merger
Therapeutic area Oncology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals